ViroGates is an international Medtech company headquartered in Denmark that was founded in 2001.

ViroGates´ product line called suPARnostic® is a commercially available test, that can measure the protein called suPAR in the blood.

More than 500 publications have followed, substantiating suPAR as one of the most promising prognostic biomarker tools for various areas of healthcare.